CLINICAL_TRIALS
trial_result
· 2008-06-19
Clinical Trial Update: Use of KC706 for the Treatment of Pemphigus Vulgaris [Phase 2]
Summary
A Phase 2 clinical trial evaluating KC706 for Pemphigus Vulgaris has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kemia, Inc | Conditions: Pemphigus Vulgaris | Phase 2 | Status: COMPLETED